A Study to Evaluate the Safety and Effectiveness of the Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer.

Overview

About this study

The purpose of this study is to confirm the performance of the CB-17-08 software as a medical device (SaMD) to help endoscopist during the colonoscopy procedure to find potential mucosal lesions, including polyps, adenomas and carcinomas, without significant noise disturbing the endoscopist attention, nor negative interference with the lesions detection than with the standard endoscopy video alone. The study will evaluate whether high-definition white-light (HDWL) colonoscopy using CB-17-08 SaMD will have a lower miss rate of clinically significant polyps, as compared to standard HDWL colonoscopy alone (the current standard of care for colonoscopy).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Male or females, aged ≥ 45 years of age.
  • Scheduled for screening or surveillance colonoscopy for CRC prevention.
  • Willingness to undergo tandem colonscopies with and without the use of CADe system CB-17-08. 
  • Able to comprehend the full nature and purpose of the study and provide signed written informed consent.

Exclusion Criteria:

  • Patients who are pregnant or are planning pregnancy during study period.
  • Patients with known history of colonic resection, radiation therapy to the abdomen or pelvis, colonic stricture, Inflammatory Bowel Disease (IBD), acute diverticulitis, lower gastrointestinal bleeding, Familial Adenomatous Polyposis (FAP), or toxic megacolon will be excluded.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

La Crosse, Wis.

Mayo Clinic principal investigator

Michael Van Norstrand, M.D., Ph.D.

Open for enrollment

Contact information:

Leandra Pake CCRP

(608)392-9719

Franzen.Leandra@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Michael Wallace, M.D.

Open for enrollment

Contact information:

Frances Cayer CCRP

(904)953-7778

Cayer.Frances@mayo.edu

Eau Claire, Wis.

Mayo Clinic principal investigator

Gregory Derfus, M.D.

Open for enrollment

Contact information:

Sarah Fix B.S.

(715) 838-3533

Fix.Sarah@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Francisco Ramirez, M.D.

Open for enrollment

Contact information:

Alexandria Evans

(480) 301-4750

Evans.Alexandria@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions